An Extension Study to Evaluate Casimersen or Golodirsen in Patients With Duchenne Muscular Dystrophy



Status:Enrolling by invitation
Conditions:Neurology, Orthopedic
Therapuetic Areas:Neurology, Orthopedics / Podiatry
Healthy:No
Age Range:7 - 23
Updated:3/7/2019
Start Date:August 2, 2018
End Date:June 30, 2026

Use our guide to learn which trials are right for you!

Long-term, Open-label Extension Study for Patients With Duchenne Muscular Dystrophy Enrolled in Clinical Trials Evaluating Casimersen or Golodirsen

The main objective of this study is to evaluate the safety and tolerability of long-term
treatment with casimersen or golodirsen in patients with Duchenne muscular dystrophy (DMD).


Inclusion Criteria:

- Completed a clinical trial evaluating casimersen or golodirsen, per protocol.

- Is between 7 and 23 years of age, inclusive, at enrollment.

Other inclusion/exclusion criteria apply.
We found this trial at
5
sites
733 North Broadway
Baltimore, Maryland 21205
(410) 955-3182
Johns Hopkins University School of Medicine Johns Hopkins Medicine (JHM), headquartered in Baltimore, Maryland, is...
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
Los Angeles, California 90095
310-825-4321
University of California at Los Angeles The University of California, Los Angeles (UCLA) is an...
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
300 Longwood Ave
Boston, Massachusetts 02115
(617) 355-6000
Boston Children's Hospital Boston Children's Hospital is a 395-bed comprehensive center for pediatric health care....
?
mi
from
Boston, MA
Click here to add this to my saved trials
225 E Chicago Ave
Chicago, Illinois 60611
(312) 227-4000
Ann & Robert H. Lurie Children's Hospital of Chicago Ann & Robert H. Lurie Children
?
mi
from
Chicago, IL
Click here to add this to my saved trials
?
mi
from
Milano,
Click here to add this to my saved trials